These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15315339)

  • 21. Expression of costimulatory CD80/CD86-CD28/CD152 molecules in nasal mucosa of patients with perennial allergic rhinitis.
    Hattori H; Okano M; Yoshino T; Akagi T; Nakayama E; Saito C; Satoskar AR; Ogawa T; Azuma M; Nishizaki K
    Clin Exp Allergy; 2001 Aug; 31(8):1242-9. PubMed ID: 11529894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B7+ T cells in myeloma: an acquired marker of prior chronic antigen presentation.
    Brown R; Murray A; Pope B; Sze D; Gibson J; Ho PJ; Joshua D
    Leuk Lymphoma; 2004 Feb; 45(2):363-71. PubMed ID: 15101725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytotoxic T lymphocyte-associated antigen-4-Ig (CTLA-4-Ig) suppresses Staphylococcus aureus-induced CD80, CD86, and pro-inflammatory cytokine expression in human B cells.
    Liu PC; Ssu CT; Tsao YP; Liou TL; Tsai CY; Chou CT; Chen MH; Leu CM
    Arthritis Res Ther; 2020 Mar; 22(1):64. PubMed ID: 32228715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus.
    Bijl M; Horst G; Limburg PC; Kallenberg CG
    Ann Rheum Dis; 2001 May; 60(5):523-6. PubMed ID: 11302879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Analysis of costimulatory molecules (CD28-CTLA-4/B7) expression on chosen mononuclear cells in adolescents with Graves' disease during methimazole therapy].
    Bossowski A; Stasiak-Barmuta A; Urban M; Rinderle C
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):93-101. PubMed ID: 15504312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increases of CD80 and CD86 Expression on Peripheral Blood Cells and their Gene Polymorphisms in Autoimmune Thyroid Disease.
    Watanabe A; Inoue N; Watanabe M; Yamamoto M; Ozaki H; Hidaka Y; Iwatani Y
    Immunol Invest; 2020 Feb; 49(1-2):191-203. PubMed ID: 31755324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors.
    Linsley PS; Greene JL; Brady W; Bajorath J; Ledbetter JA; Peach R
    Immunity; 1994 Dec; 1(9):793-801. PubMed ID: 7534620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular cloning of the cDNAs encoding the feline B-lymphocyte activation antigen B7-1 (CD80) and B7-2 (CD86) homologues which interact with human CTLA4-Ig.
    Nishimura Y; Shimojima M; Miyazawa T; Sato E; Nakamura K; Izumiya Y; Ikeda Y; Mikami T; Takahashi E
    Eur J Immunogenet; 2000; 27(5-6):427-30. PubMed ID: 11029611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chimeric co-stimulatory molecules that selectively act through CD28 or CTLA-4 on human T cells.
    Lazetic S; Leong SR; Chang JC; Ong R; Dawes G; Punnonen J
    J Biol Chem; 2002 Oct; 277(41):38660-8. PubMed ID: 12167647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD28/CTLA-4 and CD80/CD86 costimulatory molecules are mainly involved in acceptance or rejection of human liver transplant.
    Minguela A; Marín L; Torío A; Muro M; García-Alonso AM; Moya-Quiles MR; Sánchez-Bueno F; Parrilla P; Alvarez-López MR
    Hum Immunol; 2000 Jul; 61(7):658-69. PubMed ID: 10880736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of CTLA-4 substitutions on the binding of human CD80 (B7-1) and CD86 (B7-2).
    Morton PA; Fu XT; Stewart JA; Giacoletto KS; White SL; Leysath CE; Evans RJ; Shieh JJ; Karr RW
    J Immunol; 1996 Feb; 156(3):1047-54. PubMed ID: 8557978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells.
    Tekguc M; Wing JB; Osaki M; Long J; Sakaguchi S
    Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34301886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
    Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D
    Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Covalent dimerization of CD28/CTLA-4 and oligomerization of CD80/CD86 regulate T cell costimulatory interactions.
    Greene JL; Leytze GM; Emswiler J; Peach R; Bajorath J; Cosand W; Linsley PS
    J Biol Chem; 1996 Oct; 271(43):26762-71. PubMed ID: 8900156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The kinetics of CD80 and CD86 expression on antigen-presenting cells in cedar pollinosis subjects].
    Shirasaka K; Morikawa H
    Nihon Jibiinkoka Gakkai Kaiho; 2003 Aug; 106(8):823-30. PubMed ID: 14513778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population.
    Ahmed S; Ihara K; Kanemitsu S; Nakashima H; Otsuka T; Tsuzaka K; Takeuchi T; Hara T
    Rheumatology (Oxford); 2001 Jun; 40(6):662-7. PubMed ID: 11426024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional activation of proline-rich tyrosine kinase2 (PYK2) in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
    Wang M; Sun H; Zhang W; Zhang Y
    BMC Musculoskelet Disord; 2009 Nov; 10():141. PubMed ID: 19919693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune inhibitory function of bovine CTLA-4 and the effects of its blockade in IFN-γ production.
    Watari K; Konnai S; Maekawa N; Okagawa T; Suzuki Y; Murata S; Ohashi K
    BMC Vet Res; 2019 Oct; 15(1):380. PubMed ID: 31665022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monocyte activation by apoptotic cells removal in systemic lupus erythematosus patients.
    Yassin LM; Rojas M; Ramírez LA; García LF; Vásquez G
    Cell Immunol; 2010; 266(1):52-60. PubMed ID: 20863485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In situ expression of B7 and CD28 receptor families in skin lesions of patients with lupus erythematosus.
    Denfeld RW; Kind P; Sontheimer RD; Schöpf E; Simon JC
    Arthritis Rheum; 1997 May; 40(5):814-21. PubMed ID: 9153541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.